Skip to main content
Christopher Benz, MD, Oncology, San Francisco, CA

ChristopherC.BenzMD

Oncology • San Francisco, CA

Physician

Join to view full profile

Dr. Benz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Benz's full profile

Already have an account?

  • Office

    1600 Divisadero St
    San Francisco, CA 94143
    Phone+1 415-353-7070
    Fax+1 415-353-7021

Education & Training

  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1972

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1973 - 2026
  • WA State Medical License
    WA State Medical License 1973 - 2024
  • CT State Medical License
    CT State Medical License 1981 - 2001
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Elected Member The American Society for Clinical Investigation, 1991

Publications & Presentations

PubMed

Press Mentions

  • Gynecologic Disorders Suggests New Screening Options for Cardiovascular Disease, Cancer
    Gynecologic Disorders Suggests New Screening Options for Cardiovascular Disease, CancerMay 18th, 2022
  • Common Gene Variant in Three Seemingly Unrelated Gynecologic Disorders Suggests New Options for Screening for CVD and Cancers
    Common Gene Variant in Three Seemingly Unrelated Gynecologic Disorders Suggests New Options for Screening for CVD and CancersMay 10th, 2022
  • Largest Cancer Genomics Study Spurs Efforts to Promote Specialized Clinical Trials
    Largest Cancer Genomics Study Spurs Efforts to Promote Specialized Clinical TrialsApril 7th, 2018
  • Join now to see all

Grant Support

  • Mass Spectrometry To Decode PTM Patterns And Enhance The Biomarker Utility Of ERNational Cancer Institute2010–2012
  • Polyribosome Targets Mediating MRNA Decay For Cancer Prediction And TherapyNational Cancer Institute2011
  • Ucsc-Buck Inst. Genome Data Analysis Center For TCGA Research Network (GDAC)National Cancer Institute2009–2011
  • Clinical Significance Of Functionally Defective Estrogen ReceptorNational Center For Research Resources2006–2008
  • Defective Estrogen Receptors In Breast TumorsNational Cancer Institute2000–2008
  • Biology Of Breast Cancers Arising In Older WomenNational Institute On Aging2003–2007
  • Therapeutic Modulation Of Breast Cancer OncogenesNational Cancer Institute2000–2007
  • Ecological &Clin Sig Of Defective Estrogen Receptor From Human Breast TumorNational Center For Research Resources2005
  • Ecological &Clin Sig Of Defective Estrogen ReceptorNational Center For Research Resources2004
  • Developmental Research Program--Breast CancerNational Cancer Institute1995–2002
  • Development Of Membrane Receptor Targeted And Tumoricidal Breast Cancer TherapyNational Cancer Institute1995–2002
  • Defective Estrogen Receptors In Breast TumorsNational Cancer Institute1999–2000
  • Activation Of Oncogenes And Receptors In Human Breast Cancer--Ets And Her2/NeuNational Cancer Institute1996–2000
  • Therapeutic Modulation Of Breast Cancer OncogenesNational Cancer Institute1995–2000
  • Antierbb2 Antibody Induced Protein InteractionsFogarty International Center1999
  • Defective Estrogen Receptors In Human Breast TumorsNational Cancer Institute1996–1998
  • Activation Of Oncogenes And Receptors In Human Breast Cancer--Ets And Her2/NeuNational Cancer Institute1995–1998
  • Therapeutic Modulation Breast Cancer Oncogenes, EstrogenNational Cancer Institute1994
  • Activation Of Oncogenes And Receptors In Breast CancerNational Cancer Institute1991–1994
  • Therapeutic Modulation Of Breast Cancer Oncogenes &EstrNational Cancer Institute1991–1993
  • Modulation Of Receptor Signal Trandsuction.....National Cancer Institute1992
  • Activation Of Oncogenes And Receptors In Breast CancerNational Cancer Institute1990
  • Investigations Into Selectivity And Monitoring SystemsNational Cancer Institute1988–1990
  • Antiestrogen/5-Fu Drug Combinations In Breast CancerNational Cancer Institute1987–1990
  • Transforming Genes Expression In Breast CancerNational Cancer Institute1989
  • Steroids And Antimetabolites In Pancreatic CarcinomaNational Cancer Institute1985–1986
  • 5-Fluorouracil And Antiestrogens In Breast CancerNational Cancer Institute1985–1986

Dr. Christopher Benz, Dr. Christopher Benz, MD, Dr. C Benz, Dr. Christopher C. Benz